We can raise money in our new venture firms in future, says Lupin MD

In a digital health venture, I would love to go into areas where we have equity with doctors. Respiratory is one area where I am very interested in, says Nilesh Gupta, MD, Lupin

Lupin’s Managing Director NILESH GUPTA shares his thoughts about the new ventures his firm has forayed into. In conversation with Sohini Das, Gupta elaborates on how the Indian market is becoming lucrative for drug firms.

Edited excerpts:

Why did you go for diversification into diagnostics and digital health ventures?

I don’t like to call it diversification. Rather it is multiplying our offerings in India. India has very high potential. We are still small in India, at around No. 6 in the domestic pharmaceutical (pharma) market.

These ventures add more sheen to our business, while the core remains the prescription